放射组学分析用于晚期头颈癌疗效评估:遥不可及的梦想还是必然的现实?对当前证据水平的系统综述
该系统综述检索Ovid-MEDLINE和Embase数据库,评估放射组学作为晚期头颈癌疗效预测或预后工具的证据水平。多数研究结论认为放射组学是有效的预测和预后生物标志物,但研究方法学和统计建模存在显著异质性,且多数研究未经外部验证、结果可重复性面临挑战。作者认为在开展稳健的外部验证研究之前,当前证据水平仍低,建议避免仓促在多学科门诊中应用这些工具。
要点
- 多数研究结论认为放射组学是晚期头颈癌有效的预测和预后生物标志物。
- 各研究间方法学和统计建模存在显著异质性,无法进行准确的数学比较或给出明确推荐。
- 多数研究未经外部验证,结果可重复性面临挑战,当前证据水平仍低。
核心结论
- 在针对头颈癌放射组学分析方法可重复性和准确性的稳健外部验证研究完成之前,当前证据水平仍低,作者建议避免在多学科门诊中仓促应用这些工具。
研究设计与样本
- 系统综述,检索Ovid-MEDLINE和Embase数据库中的英文文献,纳入评估放射组学作为头颈癌疗效评估预测或预后工具的研究;作者原计划进行Meta分析,但因检索到的提供充分数据的研究数量少且方法学异质性过大,仅进行了结构化描述性系统综述;由两位作者使用预定义数据字段独立提取文献,分歧通过共识解决。
临床应用与阅片要点
- 作者建议在多学科门诊中避免仓促应用放射组学工具。
局限性
- 检索到的提供充分数据的研究数量少,无法进行原计划的Meta分析。
- 研究方法和统计建模存在显著异质性,妨碍准确的数学比较或给出明确推荐。
- 多数研究未经外部验证,其结果的可重复性将是一大挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The recent increase in publications on radiomic analysis as means to produce diagnostic and predictive biomarkers in head and neck cancers (HNCC) reveal complicated and often conflicting results. The objective of this paper is to systematically review the published data, and evaluate the current level of evidence accumulated that would determine clinical application.
METHODS: Data sources: Articles in the English language available on the Ovid-MEDLINE and Embase databases were used for the literature search. Study selection:Studies which evaluated the role of radiomics as a predictive or prognostic tool for response assessment in HNCC were included in this review.Study appraisal and synthesis methods: The authors set-out to perform a meta-analysis, however given the small number of studies retrieved that presented adequate data, combined with excessive methodological heterogeneity, we could only perform a structured descriptive systematic review summarizing the key findings. Independent extraction of articles was performed by two authors using predefined data fields and any disagreement was resolved by consensus.
RESULTS: Though most papers concluded that radiomics is an effective predictive and prognostic biomarker in the management of HNCC, significant heterogeneity exists in the study methodology and statistical modelling; thus precluding accurate mathematical comparison or the ability to make clear recommendations going forwards. Moreover, most studies have not been validated and the reproducibility of their results will be a challenge.
CONCLUSION: Until robust external validation studies on the reproducibility and accuracy of radiomic analysis methods on HNCC are carried out, the current level of evidence remains low, with the authors advising caution against hasty implementation of these tools in the multidisciplinary clinic.
ADVANCES IN KNOWLEDGE: This review is the first attempt to critically analyze the merits and demerits of currently published literature on tumour heterogeneity studies in HNCC, and identifies specific loop holes that need to be addressed by research groups, for a meaningful clinical translation of this potential biomarker.
引用
- Guha A, Connor S, Anjari M, et al. Radiomic analysis for response assessment in advanced head and neck cancers, a distant dream or an inevitable reality? A systematic review of the current level of evidence. Br J Radiol. 2019. PMID: 31682155. doi:10.1259/bjr.20190496
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。